ProfileGDS4718 / 210210_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 75% 70% 65% 71% 77% 67% 69% 65% 73% 74% 69% 71% 68% 67% 65% 69% 66% 69% 69% 85% 65% 66% 66% 70% 71% 64% 72% 76% 74% 71% 69% 68% 70% 68% 72% 66% 68% 69% 70% 58% 68% 71% 66% 67% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.2796575
GSM549102patient 115, normal, homogenized [OPG study]6.8139670
GSM549104patient 119, normal, homogenized [OPG study]6.5357965
GSM549108patient 138, normal, homogenized [OPG study]6.9233671
GSM549119patient 077, normal, homogenized [OPG study]7.4181177
GSM549133patient 032, cancer, homogenized [OPG study]6.6167967
GSM549139patient 042, cancer, homogenized [OPG study]6.7841669
GSM549099patient 107, normal, homogenized [OPG study]6.4561565
GSM549109patient 139, normal, homogenized [OPG study]7.1025673
GSM549110patient 046, normal, homogenized [OPG study]7.2379374
GSM549114patient 063, normal, homogenized [OPG study]6.7621869
GSM549122patient 082, normal, homogenized [OPG study]7.002271
GSM549134patient 033, cancer, homogenized [OPG study]6.7207568
GSM549136patient 036, cancer, homogenized [OPG study]6.6153167
GSM549140patient 044, cancer, homogenized [OPG study]6.4487165
GSM549111patient 047, normal, homogenized [OPG study]6.7854969
GSM549113patient 057, normal, homogenized [OPG study]6.5207366
GSM549132patient 031, cancer, homogenized [OPG study]6.8297269
GSM549137patient 038, cancer, homogenized [OPG study]6.8050269
GSM549142patient 047, cancer, homogenized [OPG study]8.1134285
GSM549100patient 110, normal, homogenized [OPG study]6.4510865
GSM549107patient 135, normal, homogenized [OPG study]6.5832866
GSM549115patient 068, normal, homogenized [OPG study]6.5775866
GSM549116patient 072, normal, homogenized [OPG study]6.9174170
GSM549120patient 078, normal, homogenized [OPG study]6.9281671
GSM549131patient 030, cancer, homogenized [OPG study]6.398664
GSM549118patient 074, normal, homogenized [OPG study]7.027572
GSM549129patient 027, cancer, homogenized [OPG study]7.4969876
GSM549123patient 088, normal, homogenized [OPG study]7.220174
GSM549124patient 006, cancer, homogenized [OPG study]6.9616171
GSM549126patient 015, cancer, homogenized [OPG study]6.7631869
GSM549128patient 025, cancer, homogenized [OPG study]6.7859668
GSM549103patient 117, normal, homogenized [OPG study]6.8371170
GSM549117patient 073, normal, homogenized [OPG study]6.6868
GSM549138patient 041, cancer, homogenized [OPG study]7.0647772
GSM549141patient 045, cancer, homogenized [OPG study]6.6388266
GSM549130patient 028, cancer, homogenized [OPG study]6.6893368
GSM549101patient 111, normal, homogenized [OPG study]6.7932169
GSM549105patient 128, normal, homogenized [OPG study]6.8472870
GSM549106patient 134, normal, homogenized [OPG study]5.9932158
GSM549112patient 048, normal, homogenized [OPG study]6.7152968
GSM549125patient 011, cancer, homogenized [OPG study]6.9444271
GSM549127patient 024, cancer, homogenized [OPG study]6.5966966
GSM549135patient 035, cancer, homogenized [OPG study]6.6577567